Rowlandmiller & Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Rowlandmiller & Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Buy	+3,085	New	+$103K	0.02%	192

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rowlandmiller & Partners's TEVA Position: Q2 2026 in Review

Rowlandmiller & Partners opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 3,085 shares worth $105K. The stake represents 0.02% of the portfolio and ranks #192 among its holdings.

676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Rowlandmiller & Partners held 3,085 shares of Teva Pharmaceutical Industries Limited worth $105K as of Q2 2026.
Teva Pharmaceutical Industries Limited was a new Rowlandmiller & Partners position in Q2 2026.
Teva Pharmaceutical Industries Limited made up 0.02% of Rowlandmiller & Partners's portfolio in Q2 2026, its #192 holding.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.